_id
691b1c5b3c536f8df2318cc0
Ticker
CURN.SW
Name
CURATIS N AG
Exchange
SW
Address
Weierweg 7, Liestal, Switzerland, 4410
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
CHF
Website
https://curatis.com
Description
Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson's disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hyperplasia, immunomodulator, epilepsy and essential tremor, thyreostatic, hereditary tyrosinemia type 1, gastroenterologic, immunomodulator, thyreostatic, tranquilizer, helicobacter pylori test, phosphate binder, special nutrition for dialysis patients, dermato corticosteroid, lead and mercury poisoning, corticostimulin, anti-fog agent, chorea associated with huntington's disease, and antiepileptic. The company also develops C-PTBE-01, which is in Phase IIb clinical trial for the treatment of peritumoral brain edema in pediatric patients; C-AM-01 that is in Phase IIa clinical trial for the prevention of severe migraine with aura; C-MOH-01, which is in Phase IIa clinical trial for the treatment and prevention of medication overuse headache; and KIN001 that is in Phase I clinical trial for the treatment of rare inflammatory and fibrotic diseases. The company is based in Liestal, Switzerland.
Last Close
12
Volume
14
Current Price
12.65
Change
-0.1
Last Updated
2026-01-01T00:04:36.815Z
Image
https://logo.clearbit.com/curatis.com
Ipo Date
-
Market Cap
59898960
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
5243000
Cost Of Revenue
3951000
Gross Profit
1292000
Operating Expenses
6534000
Operating Income
-1291000
Interest Expense
-
Pretax Income
-1297000
Net Income
-1164000
Eps
-0.240552526834833
Dividends Per Share
-
Shares Outstanding
4991580
Income Tax Expense
-
EBITDA
-
Operating Margin
-24.62330726683197
Total Other Income Expense Net
-
Cash
2045000
Short Term Investments
-
Receivables
1380000
Inventories
1433000
Total Current Assets
4960000
Property Plant Equipment
-
Total Assets
54519000
Payables
-
Short Term Debt
0
Long Term Debt
0
Total Liabilities
9959000
Equity
44560000
Bs_currency_symbol
-
Depreciation
192000
Change In Working Capital
20000
Cash From Operations
-1055000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
85000
Net Change In Cash
-970000
Cf_currency_symbol
-
PE
-
PB
1.3736889362657092
ROE
-2.6122082585278275
ROA
-2.135035492213724
FCF
-1055000
Fcf Percent
-0.20122067518596223
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
5243000
Quarters > 0 > income Statement > cost Of Revenue
3951000
Quarters > 0 > income Statement > gross Profit
1292000
Quarters > 0 > income Statement > operating Expenses
6534000
Quarters > 0 > income Statement > operating Income
-1291000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1297000
Quarters > 0 > income Statement > net Income
-1164000
Quarters > 0 > income Statement > eps
-0.240552526834833
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4838860
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-24.62330726683197
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2045000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1380000
Quarters > 0 > balance Sheet > inventories
1433000
Quarters > 0 > balance Sheet > total Current Assets
4960000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
54519000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
9959000
Quarters > 0 > balance Sheet > equity
44560000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1165000
Quarters > 0 > cash Flow > depreciation
192000
Quarters > 0 > cash Flow > change In Working Capital
20000
Quarters > 0 > cash Flow > cash From Operations
-1055000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
85000
Quarters > 0 > cash Flow > net Change In Cash
-970000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.240552526834833
Quarters > 0 > ratios > PB
1.3736889362657092
Quarters > 0 > ratios > ROE
-2.6122082585278275
Quarters > 0 > ratios > ROA
-2.135035492213724
Quarters > 0 > ratios > FCF
-1055000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.20122067518596223
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
4917000
Quarters > 1 > income Statement > cost Of Revenue
3758000
Quarters > 1 > income Statement > gross Profit
1159000
Quarters > 1 > income Statement > operating Expenses
5651000
Quarters > 1 > income Statement > operating Income
-734000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-698000
Quarters > 1 > income Statement > net Income
-476000
Quarters > 1 > income Statement > eps
-0.09837027729671864
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4838860
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-14.927801504982712
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CHF
Quarters > 1 > balance Sheet > cash
3014000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1519000
Quarters > 1 > balance Sheet > inventories
1324000
Quarters > 1 > balance Sheet > total Current Assets
5902000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
55536000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
9938000
Quarters > 1 > balance Sheet > equity
45598000
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
-4345000
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
820000
Quarters > 1 > cash Flow > cash From Operations
-825000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
4013000
Quarters > 1 > cash Flow > cash From Financing
-183000
Quarters > 1 > cash Flow > net Change In Cash
3005000
Quarters > 1 > cash Flow > currency_symbol
CHF
Quarters > 1 > ratios > PE
-0.09837027729671864
Quarters > 1 > ratios > PB
1.3424180665818677
Quarters > 1 > ratios > ROE
-1.0439054344488794
Quarters > 1 > ratios > ROA
-0.8571016997983291
Quarters > 1 > ratios > FCF
-825000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.16778523489932887
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1979000
Quarters > 2 > income Statement > cost Of Revenue
1552000
Quarters > 2 > income Statement > gross Profit
427000
Quarters > 2 > income Statement > operating Expenses
5914000
Quarters > 2 > income Statement > operating Income
-3935000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3939000
Quarters > 2 > income Statement > net Income
-3869000
Quarters > 2 > income Statement > eps
-0.8824287431377423
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4384490
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-198.8377968671046
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CHF
Quarters > 2 > balance Sheet > cash
3463000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1122000
Quarters > 2 > balance Sheet > inventories
1316000
Quarters > 2 > balance Sheet > total Current Assets
6200000
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
55311000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
329000
Quarters > 2 > balance Sheet > total Liabilities
13718000
Quarters > 2 > balance Sheet > equity
41593000
Quarters > 2 > balance Sheet > currency_symbol
CHF
Quarters > 2 > cash Flow > net Income
-3869000
Quarters > 2 > cash Flow > depreciation
528000
Quarters > 2 > cash Flow > change In Working Capital
4364000
Quarters > 2 > cash Flow > cash From Operations
3454000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
0
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
3454000
Quarters > 2 > cash Flow > currency_symbol
CHF
Quarters > 2 > ratios > PE
-0.8824287431377423
Quarters > 2 > ratios > PB
1.3334887721491597
Quarters > 2 > ratios > ROE
-9.302046017358691
Quarters > 2 > ratios > ROA
-6.994991954584079
Quarters > 2 > ratios > FCF
3454000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
1.7453259221829207
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-2087000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2092000
Quarters > 3 > income Statement > net Income
-2051000
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CHF
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
-
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
6896000
Annuals > 0 > income Statement > cost Of Revenue
5310000
Annuals > 0 > income Statement > gross Profit
1586000
Annuals > 0 > income Statement > operating Expenses
11565000
Annuals > 0 > income Statement > operating Income
-4669000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-4637000
Annuals > 0 > income Statement > net Income
-4345000
Annuals > 0 > income Statement > eps
-0.8979387707021902
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4838860
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-67.70591647331786
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
3014000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1519000
Annuals > 0 > balance Sheet > inventories
1324000
Annuals > 0 > balance Sheet > total Current Assets
5902000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
55536000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
9938000
Annuals > 0 > balance Sheet > equity
45598000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
-4345000
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
820000
Annuals > 0 > cash Flow > cash From Operations
-825000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
4013000
Annuals > 0 > cash Flow > cash From Financing
-183000
Annuals > 0 > cash Flow > net Change In Cash
3005000
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
-0.8979387707021902
Annuals > 0 > ratios > PB
1.2734400631606648
Annuals > 0 > ratios > ROE
-9.528926707311724
Annuals > 0 > ratios > ROA
-7.823753961394411
Annuals > 0 > ratios > FCF
-825000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.11963457076566125
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
40017000
Annuals > 1 > income Statement > operating Income
-40017000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-39899000
Annuals > 1 > income Statement > net Income
-34732000
Annuals > 1 > income Statement > eps
-137.06933975295
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
253390
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
1000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
140000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
12540000
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
647000
Annuals > 1 > balance Sheet > equity
11893000
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
-34743000
Annuals > 1 > cash Flow > depreciation
3000
Annuals > 1 > cash Flow > change In Working Capital
-999000
Annuals > 1 > cash Flow > cash From Operations
-4653000
Annuals > 1 > cash Flow > capital Expenditures
4000
Annuals > 1 > cash Flow > cash From Investing
5479000
Annuals > 1 > cash Flow > cash From Financing
392000
Annuals > 1 > cash Flow > net Change In Cash
1218000
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
-137.06933975295
Annuals > 1 > ratios > PB
0.25566972168502483
Annuals > 1 > ratios > ROE
-292.0373328848903
Annuals > 1 > ratios > ROA
-276.96969696969694
Annuals > 1 > ratios > FCF
-4657000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
410000
Annuals > 2 > income Statement > operating Income
-410000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-143000
Annuals > 2 > income Statement > net Income
-143000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
-
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
-
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
-
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
45
Valuation > metrics > PE
-0.240552526834833
Valuation > metrics > PB
1.3736889362657092
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-2.6122082585278275
Profitability > metrics > ROA
-23.467741935483872
Profitability > metrics > Net Margin
-0.22201029944688155
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.22349640933572712
Risk > final Score
80
Risk > verdict
Low
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
50
Prev Risks > 0
80
Prev Risks > 1
80
Prev Risks > 2
50
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T23:11:07.097Z
Earnings History > 0 > period
2022-06-30
Earnings History > 0 > report Date
2022-08-31
Earnings History > 0 > date
2022-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-12-31
Earnings History > 1 > report Date
2022-03-31
Earnings History > 1 > date
2021-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-06-30
Earnings History > 2 > report Date
2021-09-29
Earnings History > 2 > date
2021-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-12-31
Earnings History > 3 > report Date
2021-03-31
Earnings History > 3 > date
2020-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-29
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-05-28
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-06-30
Earnings History > 6 > report Date
2019-09-27
Earnings History > 6 > date
2019-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2018-12-31
Earnings History > 7 > report Date
2019-03-29
Earnings History > 7 > date
2018-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2018-06-30
Earnings History > 8 > report Date
2018-09-28
Earnings History > 8 > date
2018-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2018-03-31
Earnings History > 9 > report Date
2018-04-16
Earnings History > 9 > date
2018-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2017-06-30
Earnings History > 10 > report Date
2017-09-29
Earnings History > 10 > date
2017-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2016-12-31
Earnings History > 11 > report Date
2017-03-31
Earnings History > 11 > date
2016-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2016-06-30
Earnings History > 12 > report Date
2016-09-30
Earnings History > 12 > date
2016-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2016-03-31
Earnings History > 13 > report Date
2016-04-01
Earnings History > 13 > date
2016-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2005-12-31
Earnings History > 14 > report Date
2005-12-31
Earnings History > 14 > date
2005-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-8108.8001
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2005-09-30
Earnings History > 15 > report Date
2005-09-30
Earnings History > 15 > date
2005-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
254.9223
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2005-06-30
Earnings History > 16 > report Date
2005-06-30
Earnings History > 16 > date
2005-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-1635.4244
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2005-03-31
Earnings History > 17 > report Date
2005-03-31
Earnings History > 17 > date
2005-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-2159.2756
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2004-12-31
Earnings History > 18 > report Date
2004-12-31
Earnings History > 18 > date
2004-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-4003.12
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2004-09-30
Earnings History > 19 > report Date
2004-09-30
Earnings History > 19 > date
2004-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-1895.3891
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2002-03-31
Earnings History > 20 > report Date
2002-03-31
Earnings History > 20 > date
2002-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-2315.0304
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson's disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hyperplasia, immunomodulator, epilepsy and essential tremor, thyreostatic, hereditary tyrosinemia type 1, gastroenterologic, immunomodulator, thyreostatic, tranquilizer, helicobacter pylori test, phosphate binder, special nutrition for dialysis patients, dermato corticosteroid, lead and mercury poisoning, corticostimulin, anti-fog agent, chorea associated with huntington's disease, and antiepileptic. The company also develops C-PTBE-01, which is in Phase IIb clinical trial for the treatment of peritumoral brain edema in pediatric patients; C-AM-01 that is in Phase IIa clinical trial for the prevention of severe migraine with aura; C-MOH-01, which is in Phase IIa clinical trial for the treatment and prevention of medication overuse headache; and KIN001 that is in Phase I clinical trial for the treatment of rare inflammatory and fibrotic diseases. The company is based in Liestal, Switzerland.
Stock Price
CHF0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AThe recent 28% gain must have brightened Top Key Executive Gunter Graubach's week, Curatis Holding AG's (VTX:CURN) most bullish insider Yahoo Finance
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of CURATIS N AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2022-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
CHF 0
Cost Of Revenue
CHF 0
Gross Profit
CHF 0
Operating Expenses
CHF 0
Operating Income
CHF 0
Interest Expense
CHF 0
Pretax Income
CHF 0
Net Income
CHF 0
Income Tax Expense
CHF 0
EBITDA
CHF 0
Total Other Income Expense Net
CHF 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
CHF 0
Short Term Investments
CHF 0
Receivables
CHF 0
Inventories
CHF 0
Total Current Assets
CHF 0
Property Plant Equipment
CHF 0
Total Assets
CHF 0
Payables
CHF 0
Short Term Debt
CHF 0
Long Term Debt
CHF 0
Total Liabilities
CHF 0
Equity
CHF 0
(Last Updated 2025-06-30)
Net Income
CHF 0
Depreciation
CHF 0
Change In Working Capital
CHF 0
Cash From Operations
CHF 0
Capital Expenditures
CHF 0
Cash From Investing
CHF 0
Cash From Financing
CHF 0
Net Change In Cash
CHF 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.